American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

被引：556

作者：

Reddy, K. Rajender ^{[1
]}

Beavers, Kimberly L. ^{[2
]}

Hammond, Sarah P. ^{[3
,4
]}

Lim, Joseph K. ^{[5
]}

Falck-Ytter, Yngve T. ^{[6
]}

机构：

[1] Univ Penn, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA

[2] Med Univ S Carolina, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA

[3] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Infect Dis, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Yale Univ, Sch Med, Div Gastroenterol & Hepatol, New Haven, CT USA

[6] Case Western Reserve Univ, Dept Med, Div Gastroenterol & Hepatol, Case & VA Med Ctr, Cleveland, OH 44106 USA

来源：

关键词：

D O I：

10.1053/j.gastro.2014.10.039

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：215 / U351

页数：6

共 4 条

[1]

American Gastroenterological Association, 2013, AGA I CLIN PRACT GUI

[2]

[Anonymous], 2011, CLIN PRACTICE GUIDEL, DOI DOI 10.17226/13058

[3]

Perrillo, Robert P. ;

Gish, Robert ;

Falck-Ytter, Yngve T. .

[4]

Sultan, Shahnaz ;

Falck-Ytter, Yngve ;

Inadomi, John M. .